This year’s Consumer Electronics (CES) show, which took place January 6 – 9 in Las Vegas, highlighted some of the latest and greatest in up-and-coming healthcare technology. The following is a recap of just a few of our favorites coming out of the show.
Trials are getting increasingly more complex, and running studies globally is a business imperative – today more than ever. These complexities require a new set of methods and technologies to identify patients willing to engage in trials. We know from experience that those leveraging next-gen data management and deep analytics tools are succeeding in achieving their business objectives.
We’re pleased to announce the availability of our latest eBook: Are You Patient-Centric? Organizations with a patient-centric approach will outperform and maintain a competitive advantage over those who are solely focused on their bottom line. It’s really that simple. We know this to be true because it has been our experience for more than thirty years – and “The Patients to Find the Cure” is much more than our company’s tagline. Patients are at the center of everything we do.
And that’s why we couldn’t be more enthusiastic about the range of ways our industry is working to redefine itself around patient needs, wants, insights and knowledge.
"I Wish I Had Breast Cancer"
Meet Kerry Harvey. 24 years old. And diagnosed with pancreatic cancer – a cancer with which she only has a 3% chance of living another 12 months. Kerry wants you to know that she suffers from “cancer envy” (Pancreatic Cancer Action). She never imagined she’d feel envious of someone suffering from breast cancer, a condition with an 85% survival rate, but Kerry faces the grim prognosis of metastatic pancreatic cancer, a condition with an average life expectancy of up to six months and one that only receives 1% of research funding.
“Yes, the strap line is hard hitting and may even offend someone but it does compel you to read on – which is what we need people to do if we are to change the fortunes of pancreatic cancer (Ali Stunt of Pancreatic Cancer Action).”
Topics: BBK Worldwide, Innovative Ideas for Patient Recruitment, Matthew Stumm, CenterWatch 2nd Annual Forum, clinical trial advertising, Creative and Media, Pancreatic Cancer Action, Shock Advertising
During our recent webinar, "Patient-centric to the Core", attendees asked great, thought-provoking questions of our panelists, Christel Aprigliano (The Diabetes Collective), Claire Meunier (The Michael J. Fox Foundation), and Bonnie A. Brescia (BBK Worldwide). We answered some during the webinar, but ran out of time and couldn’t get to them all. A full summary of webinar Q&As follow; we hope it helps address some of your own questions, thoughts and concerns. If you have others, please join the conversation by posting a question in the comment section below. Also, stay tuned for an upcoming BBK eBook on this highly discussed topic.
BBK and its co-founders Joan F. Bachenheimer and Bonnie A. Brescia joined other honorees at the Institute’s award breakfast Friday, October 24, including Boston Children’s Hospital president and CEO Sandra L. Fenwick, Commonwealth Medicine executive vice chancellor Joyce A. Murphy, Brigham and Women's Hospital president Dr. Elizabeth Nabel, and Atlas Travel president and CEO Elaine Osgood. (You can find the full list in the Globe Magazine’s Women and Power Issue, available at bostonglobe.com/magazine.) BBK was also one of 11 companies to be highlighted as a "Gold Star Innovator", for its innovation in 2013.
If you're not putting your patients first, someone else will. Yesterday, BBK hosted a webinar on patient centricity in clinical research. The webinar, Patient-centric to the Core: Setting a New Standard for Engagement Strategies in Clinical Research, addresses the topic of how patient centricity is no longer a nice-to-have; it is a critical component of any study's success.
Founded in 1983 with a $30,000 loan and two military surplus desks, BBK Worldwide has become a global, multi-million dollar corporation that is changing the face of patient recruitment for clinical R&D in the pharma and biopharma industries. Today, our founding principals, Bonnie A. Brescia and Joan F. Bachenheimer have created a global enterprise – one that that is true to their philosophies of how a business, its products, services, and culture can create new opportunities for its staff, clients and benefit consumers.
If you’re not putting your patients first, someone else will. Patient-centricity is no longer a nice-to-have; it is a critical component of any study’s success. Thoughtful and effective patient engagement and retention strategies should be employed throughout the entire clinical trial process – and the patient’s contribution to clinical research and the advancement of treatment options cannot be underestimated. Regardless of the inherent complexities of study management, clinical trial sponsors have an obligation to ensure patients have the best clinical trial experience possible.
BBK Worldwide is pleased to announce its recognition as a finalist for its mobile app My Clinical Study Buddy℠ in the “Best Technological Development in Clinical Trials” category in the 2014 SCRIP Awards. The annual SCRIP Awards acknowledge and applaud the pharmaceutical industry’s highest achievers across all parts of the value chain, and recognize both corporate and individual achievement. Award winners will be announced at a ceremony in London on December 3rd.